Real World Evidence Solutions Market with COVID-19 Impact Analysis, By Component (DataSets, Consulting and Analytic), By Therapeutic Areas (Oncology, Cardiovascular, Neurology, Immunology, Others), By End-User (Pharmaceutical and Medical Devices Companies, Healthcare Providers, Healthcare Payers, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Real World Evidence Solutions Market size was valued at USD 2.44 Million in 2022, expanding at a CAGR of 8.4% from 2023 to 2030.
Methodologies and techniques for capturing data from real-world healthcare contexts, including patient registries, electronic health records, claims databases, and mobile health apps, are examples of real-world evidence solutions. These solutions seek information on the safety, efficiency, and relative efficacy of healthcare treatments across a variety of patient groups and naturalistic settings. Stakeholders in the healthcare ecosystem may acquire significant insights into treatment results, illness development, patient behaviors, and health finances by analyzing large-scale, real-world data. This evidence supplements standard clinical trial data, allowing for more informed decision-making, better patient outcomes, and the creation of evidence-based healthcare policies and treatments that take into account real-world complexity and patient experiences.
Real World Evidence Solutions Market- Market Dynamics
- Growing demand for evidence-based decision-making in healthcare to propel market demand
Policymakers, authorities, medical professionals, and pharmaceutical corporations are all aware of the limits of relying simply on conventional clinical trial data, which may not completely represent a treatment\'s real-world effectiveness and long-term impacts. RWE enables the assessment of therapies in a variety of patient groups while taking into account real-world complexity and differences, resulting in better-informed and nuanced conclusions. Furthermore, the focus on value-based medical and cost-effectiveness drives demand for RWE since it gives critical information into the real-world consequences and economic results of healthcare treatments.
Real World Evidence Solutions Market- Key Insights
- As per the analysis shared by our research analyst, the global Real World Evidence Solutions market is estimated to grow annually at a CAGR of around 8.4% over the forecast period (2023-2030)
- The Real World Evidence Solutions industry is projected to grow at a significant rate due to the growing demand for evidence-based decision-making in healthcare.
- Based on Component segmentation, Consulting and Analytic was predicted to show maximum market share in the year 2022
- Based on Therapeutic Areas segmentation, Neurology was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Real World Evidence Solutions Market- Segmentation Analysis:
The Global Real World Evidence Solutions Market is segmented on the basis of Component, Therapeutic Areas, End-User, and Region.
The market is divided into two categories based on Component: DataSets, Consulting and Analytic. The Consulting and Analytic sector dominates the market. The increased need for Real World Evidence (RWE) solutions has increased the demand for eConsulting and analytics solutions. These services assist stakeholders in successfully accessing, interpreting, and using real-world healthcare data. They allow evidence-based decision-making, improved patient outcomes, and the creation of novel healthcare initiatives by employing sophisticated analytics.
The market is divided into five categories based on Therapeutic Areas: Oncology, Cardiovascular, Neurology, Immunology, Others. The Oncology dominates the market and is likely to maintain its dominance during the forecast period. The requirement to understand treatment results, safety, and efficacy in varied cancer patient groups has increased demand for Real World Evidence (RWE) solutions in oncology. Real-world insights supplement clinical trial data, enhancing oncology research, medication development, and personalized treatment methods, eventually improving cancer care.
Real World Evidence Solutions Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several reasons have contributed to a large increase in demand for Real World Evidence (RWE) solutions in the Asia Pacific area. With such a varied and huge population, there is an urgent need to understand the real-world effect of treatment results and healthcare initiatives in this area. RWE empowers healthcare partners in the Asia Pacific to make educated choices, implement evidence-based policies, and successfully optimize healthcare resources. Furthermore, the growing use of digital health technology and electronic health records in many nations around the region has made data collecting for RWE research easier. As a consequence, RWE solutions are critical to expanding medical care and increasing patient results across Asia Pacific.
Real World Evidence Solutions Market- Competitive Landscape:
Because of the increased need for evidence-based decision-making in healthcare, the competitive environment for Real World Evidence (RWE) solutions has been quickly expanding. Several businesses and research organizations are joining this market to provide full RWE services. They provide sophisticated analytics, data integration, and knowledge of how to access and analyze real-world healthcare data. As the market grows, competition encourages innovation, which leads to the creation of more advanced RWE techniques and technology. Companies are attempting to distinguish themselves by offering customized solutions for certain therapeutic areas such as cancer or rare illnesses, as well as by collaborating with healthcare stakeholders to encourage the implementation of RWE in healthcare policy, medication development, and treatment optimization.
Recent Developments:
- In June 2023, Verana Health, a digital health firm that improves the quality of real-world data (RWD), has launched VeraSite, a system for discovering possible clinical trial locations. The newly launched subscription-based service allows clinical trial sponsors and contractual research organizations (CROs) to swiftly locate practices with clinical knowledge and prospective patient demographics that are matched to specific study protocols. This data may be used to inform site selection, ensuring that sponsors and CROs pick venues that are more aligned with research objectives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET KEY PLAYERS
- CLARIVATE PLC
- Clinigen Group plc
- Cognizant Technology Solutions Corporation
- Flatiron Health Inc.
- IBM Corporation
- ICON plc
- IQVIA Holdings Inc.
- Medpace Holdings Inc.
- Oracle Corporation
- PAREXEL International Corporation
- PerkinElmer Inc.
- PPD Inc.
- SAS Institute Inc.
- Symphony Innovation LLC
- SYNEOS HEALTH Inc.
GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT
- DataSets
- Consulting and Analytic
GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY THERAPEUTIC AREAS
- Oncology
- Cardiovascular
- Neurology
- Immunology
- Others
GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END-USER
- Pharmaceutical and Medical Devices Companies
- Healthcare Providers
- Healthcare Payers
- Others
GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Real World Evidence Solutions Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Real World Evidence Solutions Market Snippet by Component
2.1.2. Real World Evidence Solutions Market Snippet by Therapeutic Areas
2.1.3. Real World Evidence Solutions Market Snippet by End-User
2.1.4. Real World Evidence Solutions Market Snippet by Country
2.1.5. Real World Evidence Solutions Market Snippet by Region
2.2. Competitive Insights
3. Real World Evidence Solutions Key Market Trends
3.1. Real World Evidence Solutions Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Real World Evidence Solutions Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Real World Evidence Solutions Market Opportunities
3.4. Real World Evidence Solutions Market Future Trends
4. Real World Evidence Solutions Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Real World Evidence Solutions Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Real World Evidence Solutions Market Landscape
6.1. Real World Evidence Solutions Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Real World Evidence Solutions Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
7.1.2. DataSets
7.1.3. Consulting and Analytic
8. Real World Evidence Solutions Market – By Therapeutic Areas
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Areas, 2022 & 2030 (%)
8.1.2. Oncology
8.1.3. Cardiovascular
8.1.4. Neurology
8.1.5. Immunology
8.1.6. Others
9. Real World Evidence Solutions Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
9.1.2. Pharmaceutical and Medical Devices Companies
9.1.3. Healthcare Providers
9.1.4. Healthcare Payers
9.1.5. Others
10. Real World Evidence Solutions Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Real World Evidence Solutions Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Real World Evidence Solutions Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Real World Evidence Solutions Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Real World Evidence Solutions Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Real World Evidence Solutions Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Real World Evidence Solutions Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. CLARIVATE PLC
11.2.2. Clinigen Group plc
11.2.3. Cognizant Technology Solutions Corporation
11.2.4. Flatiron Health Inc.
11.2.5. IBM Corporation
11.2.6. ICON plc
11.2.7. IQVIA Holdings Inc.
11.2.8. Medpace Holdings Inc.
11.2.9. Oracle Corporation
11.2.10. PAREXEL International Corporation
11.2.11. PerkinElmer Inc.
11.2.12. PPD Inc.
11.2.13. SAS Institute Inc.
11.2.14. Symphony Innovation LLC
11.2.15. SYNEOS HEALTH Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
